Syntheses of cyclic prodrugs of RGD peptidomimetics with various macrocyclic ring sizes: evaluation of physicochemical, transport and antithrombic properties.

about

Pathways and progress in improving drug delivery through the intestinal mucosa and blood-brain barriers Comparison of diffusion coefficients for matched pairs of macrocyclic and linear molecules over a drug-like molecular weight range.

P2860

Q26852773-D3FDB7DC-12A1-44BC-AA79-ED3AF33C4CD8 Q46782509-7C509ABA-50BE-42DF-BA71-9F318C7004A7

P2860

Syntheses of cyclic prodrugs of RGD peptidomimetics with various macrocyclic ring sizes: evaluation of physicochemical, transport and antithrombic properties.

Item

http://www.wikidata.org/entity/Q44445174

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

Syntheses of cyclic prodrugs o ...... t and antithrombic properties.

@en

Syntheses of cyclic prodrugs o ...... t and antithrombic properties.

@nl

type

Item

label

Syntheses of cyclic prodrugs o ...... t and antithrombic properties.

@en

Syntheses of cyclic prodrugs o ...... t and antithrombic properties.

@nl

prefLabel

Syntheses of cyclic prodrugs o ...... t and antithrombic properties.

@en

Syntheses of cyclic prodrugs o ...... t and antithrombic properties.

@nl

P1476

Syntheses of cyclic prodrugs o ...... t and antithrombic properties.

@en

P2093

C R Xu

http://www.w3.org/2001/XMLSchema#string

H T He

http://www.w3.org/2001/XMLSchema#string

T J Siahaan

http://www.w3.org/2001/XMLSchema#string

X Song

http://www.w3.org/2001/XMLSchema#string

P2860

Orbofiban: an orally active GPIIb/IIIa platelet receptor antagonist

Platelet glycoprotein IIb-IIIa antagonists as prototypical integrin blockers: novel parenteral and potential oral antithrombotic agents.

Orally active peptidomimetic RGD analogs that are glycoprotein IIb/IIIa antagonists.

Inhibition of the alpha-nu integrins with a cyclic RGD peptide impairs angiogenesis, growth and metastasis of solid tumours in vivo.

A modified coumarinic acid-based cyclic prodrug of an opioid peptide: its enzymatic and chemical stability and cell permeation characteristics.

Characterization of the efflux transporter(s) responsible for restricting intestinal mucosa permeation of the coumarinic acid-based cyclic prodrug of the opioid peptide DADLE.

Characterization of the efflux transporter(s) responsible for restricting intestinal mucosa permeation of an acyloxyalkoxy-based cyclic prodrug of the opioid peptide DADLE.

A coumarin-based prodrug strategy to improve the oral absorption of RGD peptidomimetics.

Randomized COMparison of platelet inhibition with abciximab, tiRofiban and eptifibatide during percutaneous coronary intervention in acute coronary syndromes: the COMPARE trial. Comparison Of Measurements of Platelet aggregation with Aggrastat, Reop

Synthesis of a novel cyclic prodrug of RGD peptidomimetic to improve its cell membrane permeation.

P304

331-342

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1034/J.1399-3011.2003.00062.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2003-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10754975

http://www.w3.org/2001/XMLSchema#string

P698

12753380

http://www.w3.org/2001/XMLSchema#string

Syntheses of cyclic prodrugs of RGD peptidomimetics with various macrocyclic ring sizes: evaluation of physicochemical, transport and antithrombic properties.

about

P2860

P2860

Syntheses of cyclic prodrugs of RGD peptidomimetics with various macrocyclic ring sizes: evaluation of physicochemical, transport and antithrombic properties.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698